Synthesis of humanin and its derivatives to treat traumatic brain injury in mice

International Conference and Exhibition on Molecular Medicine and Diagnostics

August 24-26, 2015 London, UK

David Meridor

Posters-Accepted Abstracts: J Mol Genet Med

Abstract :

Humanin is a 24-amino acid peptide known for its anti-apoptotic activity, especially against neuronal cell death caused by Alzheimer
insults. Herein, we show a novel function of humanin and its derivatives, namely protection against necrosis, demonstrated both
in vitro and in vivo. The synthesis of humanin is difficult due to hydrophobic amino acids that impose aggregation on the resin.
Solid-phase peptide synthesis of humanin and its three derivatives, AGA-HNG, HNG and HN17 gave low yields. In order to avoid
aggregation and overcome difficult sequences couplings, we developed efficient synthetic procedures that are based on fragment
condensation in solution. Furthermore, native chemical ligation was applied to overcome resin aggregation for synthesis of peptides
that contain cysteine. We found that humanin and its derivatives conferred protection in PC-12 and NSC34 cell lines in which
necrosis was induced in glucose free medium by either chemohypoxia or upon staurosporine/oligomycin-A treatment. Moreover,
in-vivo protective effect was shown in traumatic brain injury model in mice, where necrosis is the main mode of the neuronal cell
death. We show that humanin derivatives antagonize the decrease in ATP levels associated with necrosis and also directly enhance the
activity of isolated ATP synthase complex, indicating that humanin derivatives target the mitochondria, regulating ATP levels. The
present findings could provide new therapeutic protocols for treatment of brain ischemic states, such as stroke, and traumatic brain
injury, conditions for which no efficient drug-based treatment is currently available.